Skip to contentClarengateINTELLIGENCE
Coverage & freshness About Clarengate
Companies/05751473

Sky Medical Technology Limited

Research and experimental development on biotechnology · Daresbury

ActiveUnited KingdomIncorporated 2006Private Limited Company
Register Ask analyst

Documents & history

Available account evidence and business events. This is not a complete filing history or document library.

Accounts to 2024-12-31

IXBRL · 210 source facts · 22 selected values

Validation findings
XBRL valid
Reporting period
2024-01-01 to 2024-12-31
Extraction status
complete
Numeric facts
139
Documents processed
1
XBRL standards validation
valid
Filing-profile validation
invalid
Parser
arelle 2.44.4
Taxonomy
FRS-102-2023-01-01.xsd
Currency
GBP
Source identifier
Prod224_2508_05751473_20241231
Source archive
Accounts_Monthly_Data-August2025.zip

Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.

Accounts to 2023-12-31

IXBRL · 204 source facts · 22 selected values

Not assessed
legacy record
Reporting period
2023-01-01 to 2023-12-31
Extraction status
Legacy / not assessed
Numeric facts
134
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2022-01-01.xsd
Currency
GBP
Source identifier
Prod224_2476_05751473_20231231
Source archive
Accounts_Monthly_Data-September2024.zip

Accounts to 2022-12-31

IXBRL · 213 source facts · 22 selected values

Not assessed
legacy record
Reporting period
2022-01-01 to 2022-12-31
Extraction status
Legacy / not assessed
Numeric facts
141
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2021-01-01.xsd
Currency
GBP
Source identifier
Prod224_0019_05751473_20221231
Source archive
Accounts_Monthly_Data-July2023.zip

Accounts to 2021-12-31

IXBRL · 212 source facts · 22 selected values

Not assessed
legacy record
Reporting period
2021-01-01 to 2021-12-31
Extraction status
Legacy / not assessed
Numeric facts
141
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2021-01-01.xsd
Currency
GBP
Source identifier
Prod224_0108_05751473_20211231
Source archive
Accounts_Monthly_Data-July2022.zip

Accounts to 2020-12-31

IXBRL · 224 source facts · 22 selected values

Not assessed
legacy record
Reporting period
2020-01-01 to 2020-12-31
Extraction status
Legacy / not assessed
Numeric facts
151
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2019-01-01.xsd
Currency
GBP
Source identifier
Prod224_0094_05751473_20201231
Source archive
Accounts_Monthly_Data-September2021.zip

Accounts to 2019-12-31

IXBRL · 212 source facts · 22 selected values

Not assessed
legacy record
Reporting period
2019-01-01 to 2019-12-31
Extraction status
Legacy / not assessed
Numeric facts
141
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2019-01-01.xsd
Currency
GBP
Source identifier
Prod224_0082_05751473_20191231
Source archive
Accounts_Monthly_Data-September2020.zip

Accounts to 2018-12-31

IXBRL · 191 source facts · 20 selected values

Not assessed
legacy record
Reporting period
2018-01-01 to 2018-12-31
Extraction status
Legacy / not assessed
Numeric facts
120
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2014-09-01.xsd
Currency
GBP
Source identifier
Prod224_0070_05751473_20181231
Source archive
Accounts_Monthly_Data-September2019.zip

Accounts to 2017-12-31

IXBRL · 191 source facts · 20 selected values

Not assessed
legacy record
Reporting period
2017-01-01 to 2017-12-31
Extraction status
Legacy / not assessed
Numeric facts
121
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2014-09-01.xsd
Currency
GBP
Source identifier
Prod224_0058_05751473_20171231
Source archive
Accounts_Monthly_Data-September2018.zip

Accounts to 2016-12-31

IXBRL · 221 source facts · 22 selected values

Not assessed
legacy record
Reporting period
2016-01-01 to 2016-12-31
Extraction status
Legacy / not assessed
Numeric facts
150
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2014-09-01.xsd
Currency
GBP
Source identifier
Prod224_0046_05751473_20161231
Source archive
Accounts_Monthly_Data-September2017.zip

Registered details

05751473
Status
Active
Type
Private Limited Company
Incorporated
2006-03-22
Jurisdiction
—
Registered office
DARESBURY SCIENCE & INNOVATION CAMPUS, KECKWICK LANE, DARESBURY, CHESHIRE, WA4 4FS

Classification

1 SIC codes
72110

Capital & company events

Reconstructed equity rounds and matched research funding.

Equity fundraising

7 SH01-derived rounds
2024-06-25
£215,376 raised
£12,308,442 estimated post-money
2024-04-18
£5,364,725 raised
£10,670,459 estimated post-money
2024-02-14
£135,000 raised
£53,057,339 estimated post-money
2023-12-01
£200,000 raised
£59,273,020 estimated post-money
2023-07-06
£335,854 raised
£52,743,768 estimated post-money
2023-03-07
£9,894,920 raised
£40,155,789 estimated post-money
2021-12-08
£49,998 raised
£118,481,721 estimated post-money

Research and innovation

5 matched grants
Development of a Protocol for Treatment, with a Neuromuscular Electro-Stimulation Device, to Improve Outcomes and Reduce Length of Stay for Critical Care PatientsLead
Innovate UK · Small Business Research Initiative · 2020-10-01 – 2020-12-31
£57,706
awarded
A New Neuro-Muscular Stimulation System for the Treatment of Chronic WoundsLead
Innovate UK · Collaborative R&D · 2018-02-01 – 2021-04-30
£506,244
awarded
A new approach for preventing DVT in THR post-operative patients using NMESLead
Innovate UK · Collaborative R&D · 2013-05-01 – 2015-07-31
£870,439
awarded
THRIVE: a Development Project to produce a pre-production prototype of a new system to assist in the treatment of osteoporosis by the stimulation of muscle pumps to augment bone blood supplyLead
Innovate UK · GRD Development of Prototype · 2012-01-01 – 2014-03-31
£186,244
awarded
Evaluation of Neuromuscular Electrical Stimulation as a New Method for Preventing VTE in Acute Stroke PatientsLead
Innovate UK · Collaborative R&D